scispace - formally typeset
M

Mary E.P. Goad

Researcher at Pfizer

Publications -  5
Citations -  998

Mary E.P. Goad is an academic researcher from Pfizer. The author has contributed to research in topics: Signal transduction & Cancer. The author has an hindex of 5, co-authored 5 publications receiving 956 citations.

Papers
More filters
Journal ArticleDOI

Regulation and Function of the Interleukin 13 Receptor α 2 During a T Helper Cell Type 2–dominant Immune Response

TL;DR: IL-13 receptor (R)α2 is a critical down-regulatory factor of IL-13–mediated tissue fibrosis induced by the parasitic helminth Schistosoma mansoni, illustrating the central role played by the IL- 13Rα2 in the down-regulation of a chronic and pathogenic Th2-mediated immune response.
Journal ArticleDOI

JNK initiates a cytokine cascade that causes Pax2 expression and closure of the optic fissure

TL;DR: It is shown that mice with a compound deficiency in Jnk expression can survive to birth, but fail to close the optic fissure (retinal coloboma), and the role of JNK to regulate BMP4 expression during optic fISSure closure is conserved in Drosophila during dorsal closure.
Journal ArticleDOI

The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis

TL;DR: It is concluded that JNK is necessary for epithelial morphogenesis and is an essential regulator of signal transduction by the EGF receptor in the epidermis.
Journal ArticleDOI

Efficacy and mechanisms of action of rmB7.2-Ig as an antitumor agent in combination with Adriamycin and Cytoxan chemotherapy.

TL;DR: Efficacy was dependent on immune activity and was not associated with toxicity, suggesting potential for recombinant human B7.2-Ig as an adjuvant to chemotherapy in promoting immune-mediated mechanisms to augment the activity of chemotherapy.